Onderneming Prana Biotechnology Limited Nasdaq
Aandelen
US7397272045
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 63 | 01-05-17 |
Geoffrey Kempler
FOU | Founder | 69 | 11-11-97 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 01-05-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Geoffrey Kempler
FOU | Founder | 69 | 11-11-97 |
Peter Marks
BRD | Director/Board Member | 68 | 29-07-05 |
Lawrence Gozlan
BRD | Director/Board Member | 45 | 08-08-11 |
Brian Meltzer
BRD | Director/Board Member | 70 | 09-12-99 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 802 360 380 | 2 436 015 074 ( 86,93 %) | 0 | 86,93 % |
Bedrijfsgegevens
Alterity Therapeutics Ltd.
350 Collins Street Level 14
3000, Melbourne
+61 3 9349 4906
http://www.alteritytherapeutics.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,36% | 54,63 mld. | |
-5,31% | 39,92 mld. | |
+37,52% | 38,82 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+25,12% | 12,21 mld. | |
+0,04% | 12,16 mld. | |
+26,04% | 11,94 mld. |